Vascular events with immune checkpoint inhibitors in melanoma or non-small cell lung cancer: A systematic review and meta-analysis

Michela Giustozzi; Cecilia Becattini; Fausto Roila; Giancarlo Agnelli; Mario Mandalà

doi:10.1016/j.ctrv.2021.102280

Back

Vascular events with immune checkpoint inhibitors in melanoma or non-small cell lung cancer: A systematic review and meta-analysis

Article 2021 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2021

1684P Cardiovascular events with immune checkpoint inhibitors in melanoma or NSCLC: A systematic review and meta-analysis

Mario Mandalà, Cecilia Becattini, F. Roila, Giancarlo Agnelli, Michela Giustozzi

Article2022

Utomilumab in Patients With Immune Checkpoint Inhibitor-Refractory Melanoma and Non-Small-Cell Lung Cancer

David S. Hong, Ajay K. Gopal, Alexander N. Shoushtari, Sandip Pravin Patel, Aiwu Ruth He, Toshihiko Doi, Suresh S. Ramalingam, Amita Patnaik, Shahneen Sandhu, Ying Chen, Craig B. Davis, Timothy S. Fisher, Bo Huang, Kolette D. Fly, Antoni Ribas

Article2019

Tumor Mutational Burden and Efficacy of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

Jong Yeob Kim, Andreas Kronbichler, Michael Eisenhut, Sung Hwi Hong, Jeonghyun Kang, Jae Il Shin, Gabriele Gamerith

Article2024

Prognostic relevance of prognostic nutritional indices in gastric or gastro-esophageal junction cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis

Shufu Hou, Dandan Song, Ruiqi Hao, Linchuan Li, Yun Zhang, Jian Kang Zhu

Article2015

Differences in the composition of the immune infiltrate in breast cancer, colorectal carcinoma, melanoma and non-small cell lung cancer: A microarray-based meta-analysis

Gautier Stoll, Laurence Zitvogel, Guido Guido Kroemer